Every month ECDC provides detailed epidemiological overview of the worldwide transmission of dengue in its weekly threat report (Communicable Diseases Threat Report).
This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 17-23 March 2024 and includes updates on SARS-CoV-2 variant classification, hepatitis A, pertussis, invasive Group A streptococcal infection, chikungunya, dengue, poliomyelitis, western equine encephalitis and cholera.
In 2020, 11 124 (12.7%) of patients staying in an intensive care unit (ICU) for more than two days presented with at least one ICU-acquired healthcare-associated infection (HAI) under surveillance (pneumonia, bloodstream infection, or urinary tract infection).
Information on autochthonous vectorial transmission of dengue in mainland EU/EEA, including location, period, number of cases, virus serotype and mode of transmission.
This is a summary of the fourth joint inter-agency report on integrated analysis of antimicrobial consumption and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals in the European Union (JIACRA IV – 2019–2021).
This report provides an integrated analysis of relationships between antimicrobial consumption in humans and food- producing animals and the occurrence of antimicrobial resistance in bacteria from humans and food- producing animals, respectively.
During the 2023 West Nile virus transmission season, and as of 4 January 2024, 709 locally acquired human cases of West Nile virus infection, including 67 deaths, were reported by nine European Union countries.
As of 4 January 2024, 728 human cases of West Nile virus infection were reported, of which 709 were locally acquired and 19 were travel-associated. In 2023, seven EU countries reported 153 outbreaks among equids and eight EU countries reported 251 outbreaks among birds.